Long-Term Efficacy and Safety of Mavacamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy: Interim Results from the MAVERICK-LTE Cohort of the MAVA-LTE Study

被引:0
|
作者
Owens, Anjali
Sherrid, Mark V.
Wong, Timothy C.
Bach, Richard G.
Wever-Pinzon, Omar
Rigolli, Marzia
Balaratnam, Ganesh
Ma, Grace
Mealiffe, Matthew E.
Edelberg, Jay M.
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A9685
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Long-term safety and efficacy of subcutaneous pasireotide in patients with Cushing's disease: interim results from a long-term real-world evidence study
    Manetti, Luca
    Deutschbein, Timo
    Schopohl, Jochen
    Yuen, Kevin C. J.
    Roughton, Michael
    Kriemler-Krahn, Ulrike
    Tauchmanova, Libuse
    Maamari, Ricardo
    Giordano, Carla
    PITUITARY, 2019, 22 (05) : 542 - 551
  • [22] Long-term safety and efficacy of subcutaneous pasireotide in patients with Cushing’s disease: interim results from a long-term real-world evidence study
    Luca Manetti
    Timo Deutschbein
    Jochen Schopohl
    Kevin C. J. Yuen
    Michael Roughton
    Ulrike Kriemler-Krahn
    Libuse Tauchmanova
    Ricardo Maamari
    Carla Giordano
    Pituitary, 2019, 22 : 542 - 551
  • [23] Long-term Safety and Efficacy of Efgartigimod in Patients With Generalized Myasthenia Gravis: Interim Results of the ADAPT plus Study
    Howard, James
    Bril, Vera
    Vu, Tuan
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan
    Murai, Hiroyuki
    Meisel, Andreas
    Beydoun, Said
    Pasnoor, Mamatha
    Guglietta, Antonio
    Ulrichts, Peter
    T'joen, Caroline
    Brauer, Edward
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    NEUROLOGY, 2022, 99 (23) : S37 - S38
  • [24] Long-Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results from the Long-Term Extension (LTE) of the Belatacept Evaluation of Nephroprotection and Efficacy as First-Line Immunosuppression Trial (BENEFIT) Study
    Larsen, C.
    Vincenti, F.
    Grinyo, J.
    Rice, K.
    Steinberg, S.
    Gaite, L.
    Moal, M.
    Pupim, L.
    Rostaing, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 312 - 312
  • [25] ABP 501 Long-Term Safety/Efficacy: Interim Results from an Open-Label Extension Study
    Cohen, Stanley
    Pablos, Jose L.
    Zhang, Nan
    Rizzo, Warren
    Muller, Gerhard
    Padmanaban, Devi
    Kivitz, Alan
    Matsumoto, Alan K.
    Kaur, Primal
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [26] EFFICACY OF FILGOTINIB (FIL) IN PATIENTS (PTS) WITH RHEUMATOID ARTHRITIS (RA): WEEK (W) 156 RESULTS FROM A LONG-TERM EXTENSION (LTE) STUDY
    Buch, M. H.
    Aletaha, D.
    Caporali, R.
    Combe, B.
    Schulze-Koops, H.
    Gottenberg, J. E.
    Tanaka, Y.
    Blanco, R.
    Takeuchi, T.
    Omoruyi, E. V. Ekoka
    Van Beneden, K.
    Rajendran, V.
    Watson, C.
    De Leonardis, F.
    Emery, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 729 - 730
  • [27] LONG-TERM SAFETY, TOLERABILITY AND EFFICACY OF EFGARTIGIMOD IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTERIM RESULTS OF THE ADAPT plus STUDY
    Howard, James
    Bril, Vera
    Tuan Vu
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan
    Murai, Hiroyuki
    Meisel, Andreas
    Beydoun, Said
    Pasnoor, Mamatha
    Guglietta, Antonio
    T'joen, Caroline
    Utsugisawa, Kimiaki
    Mantegazza, Renato
    MUSCLE & NERVE, 2022, 66 : S57 - S57
  • [28] LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF EFGARTIGIMOD IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTERIM RESULTS OF THE ADAPT plus STUDY
    Howard, James F., Jr.
    Bril, Vera
    Tuan Vu
    Karam, Chafic
    Peric, Stojan
    De Bleecker, Jan L.
    Murai, Hiroyuki
    Meisel, Andreas
    Beydoun, Said
    Pasnoor, Mamatha
    Guglietta, Antonio
    T'joen, Caroline
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    MUSCLE & NERVE, 2022, 65 : S9 - S10
  • [29] Interim results (2-year) of a French non-interventional study to assess the long-term safety and efficacy of BeneFIX
    Rothschild, C.
    Trossaert, M.
    Claeyssens, S.
    Lambert, T.
    Hassoun, A.
    Volot, F.
    Dubanchet, A.
    HAEMOPHILIA, 2012, 18 : 23 - 24
  • [30] Interim results (3-year) of a French non-interventional study to assess the long-term safety and efficacy of BeneFIX
    Rothschild, C.
    Trossaert, M.
    Claeyssens-Donadel, S.
    Lambert, T.
    Hassoun, A.
    Volot, F.
    Attal, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 428 - 428